SHL Telemedicine Ltd. to Continue Engagement of Chairman of the Board, Co-CEOs and Chief Technology Officer on terms to be Agreed, Subject to Shareholder Approval

Tel Aviv/Zurich, 8 August 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions (the “Company”), today announced that both Company and each of its Chairman of the Board, Elon Shalev, Co-CEOs, Yariv and Erez Alroy, and Chief Technology Officer, Irit Alroy (all members of the Alroy Group), wishes to continue his or her engagement with the Company on terms to be agreed upon and approved by the requisite corporate, including shareholder, approval.
For more information click here